{"id":"W1992837711","doi":"10.1139/y02-030","title":"Bradykinin-related compounds as new drugs for cancer and inflammation","year":2002,"lang":"en","type":"article","venue":"Canadian Journal of Physiology and Pharmacology","topic":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"National Cancer Institute; National Heart, Lung, and Blood Institute","keywords":"Bradykinin; In vivo; Chemistry; Cisplatin; Cell growth; Pharmacology; Receptor; Apoptosis; Antagonist; Growth inhibition; Internal medicine; Biology; Biochemistry; Medicine; Chemotherapy","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":true,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002526926,0.0003972659,0.0004347629,0.0004504453,0.000175669,0.0004413383,0.0003082037,0.0004777272,0.003835517],"category_scores_gemma":[0.0001413752,0.0001142123,0.0002124747,0.0003326017,0.0002974195,0.000528244,0.0003863007,0.001218389,0.001620089],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000342101,"about_ca_system_score_gemma":0.0002004677,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002531124,"about_ca_topic_score_gemma":0.0007118077,"domain_scores_codex":[0.9999018,0.00002139383,0.000007135734,0.00001845667,0.00003175873,0.00001952345],"domain_scores_gemma":[0.9999475,0.000007743189,0.000009181192,0.000003388231,0.00001103539,0.0000210648],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.001434166,0.0007766382,0.0005473273,0.003307329,0.0001192013,0.0007117004,0.0001784723,0.001118665,0.2323587,0.03924515,0.02602318,0.6941795],"study_design_scores_gemma":[0.0004745376,0.001930881,0.002034067,0.0003388407,0.00009834574,0.001475424,0.00003935264,0.0007618026,0.04906809,0.004082877,0.9396504,0.0000454321],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"review","genre_gemma":"empirical","genre_scores_codex":[0.02741356,0.9369925,0.006088715,0.002199597,0.00195505,0.0001653332,0.0004303342,0.0002655846,0.02448935],"genre_scores_gemma":[0.1649893,0.7739711,0.01192274,0.003735348,0.001916452,0.0003087068,0.0009712368,0.00005811083,0.04212703],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.003835517,"threshold_uncertainty_score":0.01283115,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02135826580041034,"score_gpt":0.2899934743745289,"score_spread":0.2686352085741186,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}